Ciforadenant (INN, USAN; developmental code names CPI-444 and V-81444) is an adenosine A2A receptor antagonist which is under development for the treatment of renal cell carcinoma and non-small cell lung cancer.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.